These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Müller SP, Bartels I, Stein W, Emons G, Gutensohn K, Köhler M, Legler TJ. Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461 [Abstract] [Full Text] [Related]
9. The use of maternal plasma for prenatal RhD blood group genotyping. Finning K, Martin P, Daniels G. Methods Mol Biol; 2009 Nov; 496():143-57. PubMed ID: 18839110 [Abstract] [Full Text] [Related]
17. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. Scheffer PG, van der Schoot CE, Page-Christiaens GC, de Haas M. BJOG; 2011 Oct; 118(11):1340-8. PubMed ID: 21668766 [Abstract] [Full Text] [Related]